PYC — PYC Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- AU$339.69m
- AU$315.60m
- AU$15.89m
- 41
- 17
- 90
- 50
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 6.18 | 25.4 | 51.5 | 29.1 | 15.6 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.011 | 0.083 | 0.186 | 10.1 | 16.3 |
Prepaid Expenses | |||||
Total Current Assets | 6.22 | 25.6 | 51.8 | 39.2 | 31.9 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.483 | 1.14 | 1.49 | 1.63 | 1.04 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 6.7 | 31.5 | 57.9 | 45.4 | 37.2 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.402 | 0.706 | 3.3 | 4.39 | 8.41 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.402 | 3.59 | 4.9 | 6 | 9.42 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 6.3 | 28 | 53 | 39.4 | 27.7 |
Total Liabilities & Shareholders' Equity | 6.7 | 31.5 | 57.9 | 45.4 | 37.2 |
Total Common Shares Outstanding |